Company
Nucyrna Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
NuCyRNA Therapeutics aims to transform RNA-targeting therapeutics by co-targeting nuclear and cytoplasmic RNAs, starting in neurodegenerative diseases.
Loading relationship preview